Avastin Pits Breast Cancer Patients Against FDA Experts

Priscilla Howard, who has metastatic breast cancer, has been taking the drug Avastin for a little more than two years and has seen a remarkable difference in the progression of her disease, she told a panel of experts at the U.S. Food and Drug Administration during the first day of a two-day hearing that pits the FDA's Center for Drug Evaluation and Research against Genentech, Avastin's manufacturer. "I am progression free but not cancer free," said Howard, one of a handful of Avastin...Full Story
Commenting on this article is closed.